CATALOGO DEI PRODOTTI DELLA RICERCA

MAULE, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 910
EU - Europa 821
AS - Asia 655
SA - Sud America 144
AF - Africa 40
Continente sconosciuto - Info sul continente non disponibili 29
OC - Oceania 1
Totale 2.600
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 865
RU - Federazione Russa 493
SG - Singapore 303
IT - Italia 139
BR - Brasile 106
VN - Vietnam 86
CN - Cina 84
HK - Hong Kong 72
BD - Bangladesh 46
DE - Germania 41
GB - Regno Unito 33
CA - Canada 30
FR - Francia 23
FI - Finlandia 21
IN - India 17
SE - Svezia 17
IE - Irlanda 15
ZA - Sudafrica 13
JP - Giappone 11
KR - Corea 10
NL - Olanda 10
ES - Italia 9
MX - Messico 9
AR - Argentina 8
PL - Polonia 8
EC - Ecuador 7
BJ - Benin 6
CO - Colombia 6
ID - Indonesia 6
PY - Paraguay 6
NG - Nigeria 5
TG - Togo 5
CL - Cile 4
MA - Marocco 4
AZ - Azerbaigian 3
SA - Arabia Saudita 3
TR - Turchia 3
VE - Venezuela 3
AT - Austria 2
GP - Guadalupe 2
IL - Israele 2
JO - Giordania 2
NO - Norvegia 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
AO - Angola 1
AU - Australia 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EG - Egitto 1
HR - Croazia 1
IQ - Iraq 1
KE - Kenya 1
KW - Kuwait 1
LT - Lituania 1
MD - Moldavia 1
MG - Madagascar 1
MZ - Mozambico 1
PE - Perù 1
PH - Filippine 1
PR - Porto Rico 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TH - Thailandia 1
TJ - Tagikistan 1
Totale 2.572
Salva come PNG Salva come JPEG
Città #
Moscow 190
Singapore 160
Ashburn 145
San Jose 139
Dallas 73
Hong Kong 71
Council Bluffs 50
Verona 50
New York 45
Los Angeles 27
Beijing 24
Munich 23
Ho Chi Minh City 22
Chandler 21
The Dalles 18
Santa Clara 16
Dublin 15
Hanoi 15
São Paulo 15
Turku 13
Johannesburg 12
Buffalo 11
Milan 11
Tokyo 11
Amsterdam 10
London 10
Montreal 10
Orem 9
Brooklyn 8
Denver 8
Phoenix 8
Redondo Beach 8
Chicago 7
Warsaw 7
Boston 6
Cotonou 6
Haiphong 6
Jacksonville 6
McKinney 6
Mexico City 6
Padova 6
Abuja 5
Helsinki 5
Miami 5
Mumbai 5
Nuremberg 5
Palermo 5
Rome 5
Sindelfingen 5
Stockholm 5
Toronto 5
Bari 4
Brasília 4
Da Nang 4
Houston 4
Lomé 4
Manchester 4
Porto Alegre 4
Rio de Janeiro 4
Seattle 4
Acalanes Ridge 3
Asunción 3
Baku 3
Calgary 3
Chennai 3
City of London 3
Cleveland 3
Jakarta 3
Kent 3
Lappeenranta 3
Lawrence 3
Naples 3
Phú Thọ 3
Pittsburgh 3
Poplar 3
Princeton 3
Quito 3
St Louis 3
Ankara 2
Atlanta 2
Barbacena 2
Bergamo 2
Biên Hòa 2
Boardman 2
Bắc Giang 2
Bến Tre 2
Camden 2
Casablanca 2
Chattanooga 2
Chions 2
Ciudad del Este 2
Cologna Veneta 2
Contagem 2
Curitiba 2
Dhaka 2
El Cajon 2
Fortaleza 2
Governador Valadares 2
Guangzhou 2
Lancaster 2
Totale 1.488
Salva come PNG Salva come JPEG
Nome #
Onset of eosinophilic granulomatosis with polyangiitis in a patient treated with an IL-5 pathway inhibitor for severe asthma 166
Successful switching from mepolizumab to dupilumab in a patient with EGPA in remission phase and persistent nasal polyposis 161
Low‑dose anti‑IL 5 treatment in idiopathic hypereosinophilic syndrome: towards a precision medicine approach for remission maintenance 155
Profiling blood hypereosinophilia in patients on dupilumab treatment for respiratory conditions: a real-life snapshot 153
Mepolizumab 100 mg in severe asthmatic patients with EGPA in remission phase 146
Benralizumab Efficacy in Late Non-Responders to Mepolizumab and Variables Associated with Occurrence of Switching: A Real-Word Perspective 145
Hidden Comorbidities in Asthma: A Perspective for a Personalized Approach 143
Diagnosis, management and therapeutic options for eosinophilic esophagitis 127
Comment on: Onset of eosinophilic granulomatosis with polyangiitis in a patient treated with an IL-5 pathway inhibitor for severe asthma: reply 127
Unlocking the Long-Term Effectiveness of Benralizumab in Severe Eosinophilic Asthma: A Three-Year Real-Life Study 122
Profiling severe asthma: Any relevance for age? An analysis from Severe Asthma Network Italy (SANI) cohort 121
Extracellular Vesicles in Asthma: Intercellular Cross-Talk in TH2 Inflammation 120
Epidemiology of the relationship between allergic bronchopulmonary aspergillosis and asthma 118
Diagnosis and Management of Allergic Rhinitis in Asthmatic Children 115
Dupilumab Efficacy on Asthma Functional, Inflammatory, and Patient-Reported Outcomes across Different Disease Phenotypes and Severity: A Real-Life Perspective 110
Biologics for eosinophilic granulomatosis with polyangiitis 99
Eosinophilic granulomatosis with polyangiitis onset in severe asthma patients on monoclonal antibodies targeting type 2 inflammation: Report from the European EGPA study group 94
Managing Patients with Hypereosinophilic Syndrome: A Statement from the Italian Society of Allergy, Asthma, and Clinical Immunology (SIAAIC) 92
Reply to "Mepolizumab in patients with eosinophilic granulomatosis with polyangiitis in remission: What is the right dose?" 92
Trends of T2 and Non-T2 Cytokines During Mepolizumab Treatment in Different Asthma Patient Subgroups 79
Role of body anthropometry in severe asthmatic patients: Evidences from the Severe Asthma Network in Italy (SANI) registry 76
When hypereosinophilia occurs during dupilumab therapy: evidence-based strategies for clinical management in respiratory indications 18
Safety of anti-IL-5 compounds for the treatment of eosinophilic asthma with a focus on special populations 12
Traditional biomarkers and clinical hallmarks in the frame of epithelial driven airways inflammation 9
Totale 2.600
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.198
article - articoli 9.198
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.396
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20228 0 0 0 1 1 0 0 1 0 0 2 3
2022/202375 4 6 9 6 7 19 4 3 8 2 4 3
2023/2024123 5 5 10 15 9 25 7 2 1 11 27 6
2024/2025405 14 15 14 41 12 7 6 40 64 26 32 134
2025/20261.742 90 107 81 354 481 102 111 88 123 81 39 85
2026/2027208 25 49 49 85 0 0 0 0 0 0 0 0
Totale 2.600